ISRCTN22691979已完成未知
The protective effect of Xinkeshu tablets on vascular function in patients with coronary artery disease combined with hypertension: a randomized controlled study.
Shandong Wohua Pharmaceutical Co Ltd0 个研究点目标入组 120 人开始时间: 2020年2月5日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
2021 Results article in https://doi.org/10.1155/2021/5561272 (added 28/03/2023)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18-70 years
- •2. Diagnosed with hypertension and coronary artery disease and have received regular coronary heart disease secondary prevention drugs and antihypertensive drugs
- •3. Baseline GAD-7 and PHQ-9 score were both between 5-14 points
- •4. Have given written informed consent prior to study participation
排除标准
- •1. Severe liver or kidney dysfunction or malignant tumors
- •2. Allergic to any component of Xinkeshu tablet
- •3. Cardiovascular or cerebrovascular accident within previous 3 months
- •4. Pregnant or lactating women
研究者
相似试验
Unknown
4 期
Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina PectorisCoronary Heart DiseaseStable AnginaNCT04270279Guang'anmen Hospital of China Academy of Chinese Medical Sciences120
招募中
4 期
Clinical study of Shenshao tablet on improving exercise tolerance of patients with chronic ischemic heart failure (qi deficiency and blood stasis syndrome)chronic ischemic heart failure (qi deficiency and blood stasis syndrome)ITMCTR2100004280The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Unknown
4 期
Safety and Efficacy of Shenyankangfu Tablets for Chronic Kidney DiseaseChronic Kidney DiseaseNCT02885857Chen Xiangmei1,500
尚未招募
4 期
The protective effect of Guanxinning on panvascular disease in patients with stable angina pectorisStable coronary heart diseaseITMCTR2200005556Hangzhou Hospital of Traditional Chinese Medicine
进行中（未招募）
不适用
Effectiveness of Yangxue Qingnao Granules in Preventing Post Thrombolytic Hemorrhage Transformation in Patients With Acute Cerebral InfarctionStroke, Acute IschemicNCT06344312Peking University Third Hospital60